---
category: news
title: "QurAlis and Unlearn Announce Collaboration to Accelerate and Optimize ALS Clinical Trials With Generative Artificial Intelligence Technologies"
excerpt: "Collaboration will leverage Unlearn's AI-powered digital twins in QurAlis' clinical trials for their leading ALS therapies CAMBRIDGE, Mass. and SAN FRANCISCO,  /PRNewswire/ -- QurAlis Corporation, a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets,"
publishedDateTime: 2023-06-27T12:03:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/06/27/9839450.htm"
webUrl: "https://technews.tmcnet.com/news/2023/06/27/9839450.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "6s62L+s+k8qmPV5XYaB2tE2VcsuPJs3SpoFwUeakMF4V9ADFF2q04uKrakkhsOsn4KrfhveFBCJHyLmqc4lqhH/ljocL6b6KDI+WNBvHjw79vYk9x763l0cKuKLrjWdmdp2fIjWBDyKTXcUI0pQiLI97eyvENwXcFZgT1RoywFyC54Jih7nAB7ttGLgUTHSF/weigDZ8JiHWSJDY7873PW3QW4XbW1s21hIb/1cxqBppvzbJmf9+IEgQJCwffg88YUoZpAis0uL40DLwslSON8RsjQSAfc91tW3r/W1PzBMkAiB3iziq1O8BZRFlHsHWWuaXSj+97U9aEERYyb2rvPMw9jUM/pa5apHuMt89S/A=;EgHD/9dQv0JUE/MZ/kg4hA=="
---

